rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Neuronetics, Inc.

STIM · Nasdaq

Health CareMedical DevicesJust started movingNeurotech

STIM stood above a rising 150-day average in 14 of the last 52 weekly readings, including each of the last 14 weeks. It is 2.3% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
14 in a row
Industry in uptrend
29% -5 in 4 wk
Insider buys, 12 months
$9.6M
Insider sales, 12 months
$564K
Officials’ trades on record
0
Institutions holding
85 (-10)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 14 of 52 weeks.

21 Apr – 20 Oct
19%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$12.3M$0$6.6MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months14
Sale orders, 12 months11
Buyers · sellers1 · 3
WhoDidSharesTraded
Jorey Chernett10% ownerbought14,000at $3.1614 Aug 2026filed 17 Aug 2026
Jorey Chernett10% ownersold100at $3.2113 Aug 2026filed 17 Aug 2026
Jorey Chernett10% ownerbought35,000at $1.7814 Jul 2026filed 15 Jul 2026
Jorey Chernett10% ownerbought100,000at $1.1719 May 2026filed 20 May 2026
Jorey Chernett10% ownerbought475,000at $1.3412 May 2026filed 13 May 2026
Jorey Chernett10% ownerbought100,000at $1.5121 Apr 2026filed 22 Apr 2026
Jorey Chernett10% ownerbought100,000at $1.5820 Apr 2026filed 22 Apr 2026
Jorey Chernett10% ownerbought385,442at $1.2530 Mar 2026filed 30 Mar 2026
Jorey Chernett10% ownerbought500,000at $1.3527 Mar 2026filed 30 Mar 2026
Jorey Chernett10% ownerbought25,000at $1.4426 Mar 2026filed 27 Mar 2026
Jorey Chernett10% ownerbought125,000at $1.4025 Mar 2026filed 27 Mar 2026
Jorey Chernett10% ownerbought169,472at $1.4120 Mar 2026filed 23 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders85-10 on the quarter
New · exited18 · 29
Reported value$48.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Madryn Asset Management, LPadded · filed 19 Aug 202618,540,488$24.1M+64,595+0.3%
UBS Group AGreduced · filed 13 Aug 20262,279,099$3.0M-591,499−20.6%
WEXFORD CAPITAL LPadded · filed 14 Aug 20262,002,625$2.6M+1,301,664+185.7%
FourWorld Capital Management LLCadded · filed 14 Aug 20261,744,142$2.3M+254,820+17.1%
Lane Generational LLCreduced · filed 13 Aug 20261,633,372$2.1M-141,252−8.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20261,507,097$2.0M-540,878−26.4%
MASTERS CAPITAL MANAGEMENT LLCunchanged · filed 14 Aug 20261,000,000$1.3M00.0%
AdvisorShares Investments LLCadded · filed 11 Aug 2026742,795$966K+125,602+20.4%
Ikarian Capital, LLCunchanged · filed 14 Aug 2026701,182$912K00.0%
BlackRock, Inc.reduced · filed 7 Aug 2026596,622$776K-1,721,915−74.3%
31 Mar 2023 – 30 Jun 2026
426893Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Jorey Chernett Company insider10% owner · last 14 Aug 202614 · 0
Nir Naor Company insiderEVP, CFO & Treasurer · last 23 Jul 20260 · 0
Avinash Amin Company insiderDirector · last 15 Jun 20260 · 0
Madryn Asset Management, LP Company insider10% owner · last 15 Jun 20260 · 1
Madryn Health Partners Ii, Lp Company insider10% owner · last 15 Jun 20260 · 0
Glenn P. Muir Company insiderDirector · last 28 May 20266 · 0
Megan Rosengarten Company insiderDirector · last 28 May 20260 · 0
Robert Cascella Company insiderDirector · last 28 May 20269 · 0
Sasha Cucuz Company insiderDirector · last 28 May 20260 · 0
Sheryl L. Conley Company insiderDirector · last 28 May 20260 · 2
Daniel L. Reuvers Company insiderPresident and CEO · last 23 Mar 20260 · 0
Keith J. Sullivan Company insiderOther · last 19 Mar 20260 · 26

Same industry

RCEL Avita MedicalLeading+108%
HTFL HeartflowLeading+59%
ATRC AtriCureLeading+52%
HAE HaemoneticsLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202548.5%
Operating profit marginFY 2025 · to 31 Dec 2025-21.1%
Free cash flow marginFY 2025 · to 31 Dec 2025-14.2%
Return on capital employedFY 2025 · to 31 Dec 2025-28.3%
Debt to equityFY 2025 · to 31 Dec 20252.94×
Interest coverFY 2025 · to 31 Dec 2025-4.14×
Research spendFY 2025 · to 31 Dec 20254.4%
Share count trendFY 2025 · to 10 Mar 20260.4%
Cash and equivalentsFY 2025 · to 31 Dec 2025$28.1M
Free cash flowFY 2025 · to 31 Dec 2025−$21.2M

Analyst forecasts

No analyst forecasts yet.